中文 | English
Return
Total: 3075 , 1/308
Show Home Prev Next End page: GO
Author:( Rong XU)

1.Comparison of Legal Liability between US FDCA and Drug Administration Law of PRC

Rong XU ; Rong SHAO

China Pharmacy 1991;0(03):-

2.Enlightenment of American Drug Recall System on Drug Safety in China

Rong XU ; Rong SHAO

China Pharmacy 1991;0(06):-

3.The role of serum creatinine or Cystatin C in chronic kidney disease staging and prognosis assessment

Rong XU

Chinese Journal of Laboratory Medicine 2014;(6):415-419

4.Simultaneous Determination of 7 Flavonoids in Fengliaochangweikang Capsules and Optimization of Ex-traction Process for Total Flavones

Rong XU

China Pharmacist 2017;20(2):259-262

5.Potency Determination of Lonicera Granule Based on Bacterial Inhibitory Activity

Rong XU

China Pharmacist 2016;19(2):369-371

7.Current status and prospects of quantitative immunoassay technologies

Huizhong WANG ; Rong XU

Chinese Journal of Laboratory Medicine 2017;40(6):478-480

8.Clinical study on treatment of irritable bowel syndrome by massage combined with microecological regulators

Guochao XU ; Bing RONG

Chinese Journal of Biochemical Pharmaceutics 2017;37(8):418-419,422

9.Antihypertensive therapy and prevent coronary disease

Dingli XU ; Rong HUANG

Chinese Journal of Practical Internal Medicine 2003;0(01):-

10.THE IMMUNOLOGIC EFFECT OF PARAOXON-TETANUS TOXOID ON RABBITS

Kangtai RONG ; Qinhui XU ;

Medical Journal of Chinese People's Liberation Army 1981;0(06):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 3075 , 1/308 Show Home Prev Next End page: GO